Curaleaf International(OTC:CURLF), a leading cannabis company, is expanding its footprint across the UK, Germany and Poland. This strategic expansion is not only about entering new markets but also about outpricing the illegal cannabis trade. What drives their decision to enter specific markets? How do they navigate the complex regulatory landscape?

Curaleaf recently announced a first-quarter revenue of $339 million, reflecting a 2% increase year-over-year with an adjusted gross margin of 48%. Despite a net loss of $48.3 million due to ongoing investments, the company's market cap stands at $4.12 billion.

In an exclusive interview with Benzinga Cannabis,Juan Martinez...